Evidence map›Paper›PMID 34259631›Full record

ArticleeLife2021

Loss of Tsc1 in cerebellar Purkinje cells induces transcriptional and translation changes in FMRP target transcripts.

Jasbir Singh Dalal, Kellen Diamond Winden, Catherine Lourdes Salussolia, Maria Sundberg, Achint Singh, Truc Thanh Pham, Pingzhu Zhou, William T Pu, Meghan T Miller, Mustafa Sahin

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Tuberous sclerosis complex.Nature reviews. Disease primers · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. mTOR-Dependent Spine Dynamics in Autism.Frontiers in molecular neuroscience · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jasbir Singh Dalal *Department of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States.
Kellen Diamond Winden *Department of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States.ORCID 0000-0001-5816-3724
Catherine Lourdes SalussoliaDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States.ORCID 0000-0003-0168-3205
Maria SundbergDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States.ORCID 0000-0002-6623-4411
Achint SinghDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States.
Truc Thanh PhamDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States.
Pingzhu ZhouDepartment of Cardiology, Boston Children's Hospital, Boston, United States.
William T PuDepartment of Cardiology, Boston Children's Hospital, Boston, United States.
Meghan T MillerRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Mustafa SahinDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States.ORCID 0000-0001-7044-2953
Boston Children's Hospital · USRoche (Switzerland) · CH

Funding

Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
CH/BIDMC/Harvard Medical School Neurology Resident Research Education Program Competing RenewalR25NS070682 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI PODURI, ANNAPURNA, SAPER, CLIFFORD B · 2010 to 2023
$4.5M
Molecular Mechanisms of Neuronal Hyperactivity in Tuberous Sclerosis ComplexK08NS112598 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WINDEN, KELLEN · 2020 to 2024
$963k
NICHD NIH HHS U54 HD090255NINDS NIH HHS K08 NS112598NINDS NIH HHS R25 NS070682
6 · The paper itself

Abstract

Tuberous sclerosis complex (TSC) is a genetic disorder that is associated with multiple neurological manifestations. Previously, we demonstrated that

Indexed as

AnimalsDisease Models, AnimalFragile X Messenger Ribonucleoprotein 1Gene ExpressionMiceNerve Tissue ProteinsPurkinje CellsRibosomesTuberous SclerosisTuberous Sclerosis Complex 1 ProteinFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1Nerve Tissue ProteinsShank2 protein, mouseTsc1 protein, mouseTuberous Sclerosis Complex 1 ProteinautismFMRPmousemTORneuroscienceribosometranslationTuberous Sclerosis

Identifiers

PMID34259631
PMCPMC8279760
OpenAlexW3178350184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.